Tudor Investment Corp
SCMP

Tudor Investment Corp’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Tudor Investment Corp’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,586
Closed -$174K – 1355
2017
Q2 		$174K Sell
16,586
-51,185
-76% -$522K 0.01% 914
2017
Q1 		$745K Sell
67,771
-40
-0.1% -$464 0.02% 505
2016
Q4 		$919K Buy
+67,811
New +$946K 0.02% 409
2016
Q3 		– Sell
-18,000
Closed -$197K – 1871
2016
Q2 		$197K Sell
18,000
-25,846
-59% -$289K ﹤0.01% 1412
2016
Q1 		$479K Buy
43,846
+12,838
+41% +$162K 0.01% 968
2015
Q4 		$536K Sell
31,008
-15,917
-34% -$285K 0.02% 831
2015
Q3 		$932K Buy
46,925
+31,716
+209% +$727K 0.03% 416
2015
Q2 		$250K Buy
15,209
+2,000
+15% +$34.7K 0.01% 1211
2015
Q1 		$206K Buy
13,209
+648
+5% +$10K 0.01% 1292
2014
Q4 		$179K Sell
12,561
-200
-2% -$2.11K 0.01% 1295
2014
Q3 		$83K Buy
+12,761
New +$84.8K ﹤0.01% 1288

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tudor Investment Corp's SCMP Position: Q3 2017 in Review

Tudor Investment Corp sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 16,586 shares — an estimated $174K sold.

Tudor Investment Corp first reported a position in SCMP in Q3 2014 and held it in 11 quarters. The position peaked at $932K in Q3 2015. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • Tudor Investment Corp reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 16,586 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $174K.
  • Tudor Investment Corp first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2014 and held it in 11 quarters.
  • Tudor Investment Corp's Sucampo Pharmaceuticals, Inc. position peaked at $932K in Q3 2015.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.